focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.50
Bid: 44.00
Ask: 46.00
Change: 0.50 (1.12%)
Spread: 2.00 (4.545%)
Open: 44.50
High: 45.00
Low: 44.50
Prev. Close: 44.50
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Synthomer predicts revenue decline amid challenges

Tue, 30th Jan 2024 12:27

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Berkeley Energia Ltd - Spain-focused clean energy company, focused on bringing the Salamanca project in Western Spain to production - Spot uranium prices jump 27% in the quarter to December 31, ending at USD91 per pound, and further rise to about USD100 per pound in January. "The outlook for nuclear power and the uranium market continued to strengthen during the quarter," Berkeley Energia says. Meanwhile, disagrees with decision by High Court of Justice of Castilla y Leon in Spain. The court upheld appeals to revoke judgements for authorisation of exceptional use of the land and the urbanism licence. Berkeley Energia plans to appeal the judgement at Spain's Supreme Court under Spanish law "to defend its position and take all necessary actions to preserve its rights."

----------

Cambridge Cognition Holdings PLC - Cambridgeshire, England-based company which develops and markets digital solutions to assess brain health - Swings to adjusted operating profit of GBP900,000 in 2023 from a loss of GBP2.1 million in 2022. Revenue grows 7.1% to GBP13.5 million in 2023 from GBP12.6 million. Looking ahead, company says: "There has been considerable merger & acquisition activity by large pharmaceutical companies in the central nervous system drug development sector recently and, together with an improving global economic outlook, that is expected to prompt further investment in CNS clinical trials." Chief Executive Officer Matthew Stork adds: "Despite challenging market conditions during 2023, the company has strengthened its technology platforms and commercial offering and is positioned to capitalise on the anticipated growth in the CNS drug development market. We continue to focus on delivering profitable growth and driving success over the medium-term." Cambridge Cognition will release its 2023 results in April.

----------

Diversified Energy Co PLC - owner of US oil and gas wells - Average net daily production edges up 1.3% to 136,800 barrels of oil equivalent in 2023, from 135,000 in 2022. Estimated adjusted earnings before interest, tax, depreciation and amortisation are set to rise at least 7.4% to between USD540 million and USD545 million in 2023, from USD503 million in 2022. CEO Rusty Hutson says: "Despite a challenging commodity price environment, we generated strong full year results, including growing Ebitda to a record level that exceeded consensus expectations," adding: "Diversified continues to grow as a solutions-based business, making it the right company at the right time."

----------

Flowtech Fluidpower PLC - Wilmslow, England-based supplier of technical fluid power products - Revenue in Great Britain declines 6.2% to GBP79.3 million in 2023, from GBP84.5 million in 2022. In Ireland, revenue climbs 13% to GBP22.0 million from GBP19.5 million. In the Benelux countries, revenue edges up 0.5% to GBP10.8 million. The company says that underlying profit for 2023 is anticipated to be in line with market expectations. Cites market expectations of underlying earnings before interest and tax of GBP6.0 million and underlying pretax profit of GBP4.6 million. Chair Roger McDowell says: "In 2023, we welcomed Mike England as our new CEO. With some significant team changes, he has focussed on implementing the near term performance improvement plan and the refreshed strategy to enable the firm platform from which the business can grow over the medium term. Whilst 2023 has been a more difficult year, I am confident that the actions Mike and his team are taking will drive strong returns in shareholder value."

----------

Harworth Group PLC - focused on the regeneration of land and property for sustainable development and investment - Expects EPRA net disposal value as at December 31 to be slightly ahead of current market consensus of 194.0 pence, which has a range of 189.5p to 195.6p. For December 31, 2022, the company had reported an EPRA NDV of 196.5p. The company says that its anticipated EPRA NDV "is the result of management actions undertaken on development sites to unlock high value uses, and positive progress with planning applications, which have underpinned valuation gains". Chief Executive Officer Lynda Shillaw says: "As we enter 2024, there are some signs of optimism in the macro environment whilst our key markets remain characterised by structural undersupply. We are encouraged that we are seeing continued good demand into the new year for our serviced residential land as well as occupier interest in our employment sites."

----------

Synthomer PLC - Essex, England-based chemicals manufacturer - Anticipates revenue decline of 16% to GBP2.0 billion in 2023 from GBP2.38 billion in 2022. Adjusted Ebitda will be between GBP140 million and GBP144 million in 2023. For 2022, Synthomer had reported Ebitda of GBP249.2 million. Year-end net debt is expected to decrease 51% to GBP499 million, ahead of its own expectations, from GBP1.02 billion a year prior. Synthomer cites "strong cash delivery in the final quarter" for the net debt reduction. The company says trading in the fourth quarter was consistent with trends throughout the year, with subdued volumes and limited visibility amid ongoing challenging macroeconomic conditions in the chemicals industry. Looking ahead, CEO Michael Willome says: "In the near term, our focus remains on enhancing our strong positions in key speciality end-markets, optimising our business portfolio and cost position, and sustaining our demonstrated ability to generate free cash flow despite the challenging demand environment."

----------

By Tom Budszus, Alliance News slot editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
13 Jun 2023 14:45

Cambridge Cognition wins £2m cancer therapy trial contract

(Sharecast News) - Brain health assessment specialist Cambridge Cognition has secured a £2m contract for a significant cancer therapy trial, it announced on Tuesday.

Read more
13 Jun 2023 10:05

Cambridge Cognition inks GBP2 million contract on cancer therapy trial

(Alliance News) - Cambridge Cognition Holdings PLC on Tuesday said that it has won a GBP2 million contract for a cancer therapy trial, for which it will provide its proprietary cognitive assessments.

Read more
3 May 2023 17:21

Cambridge Cognition revenue climbs despite swing to annual loss

(Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it had a "transformative" 2022, as revenue climbed 25% against the previous year.

Read more
26 Apr 2023 15:52

UK earnings, trading statements calendar - next 7 days

Thursday 27 April 
AstraZeneca PLCTrading Statement
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
Capricorn Energy PLCFull Year Results
GCP Infrastructure Investments LtdTrading Statement
HSS Hire Group PLCFull Year Results
Howden Joinery Group PLCTrading Statement
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
Inspecs Group PLCFull Year Results
J Sainsbury PLCFull Year Results
Lancashire Holdings LtdTrading Statement
Literacy Capital PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
Molten Ventures PLCTrading Statement
Novacyt SAFull Year Results
Petrofac LtdFull Year Results
PPHE Hotel Group LtdTrading Statement
Schroders PLCTrading Statement
Shield Therapeutics PLCFull Year Results
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Synairgen PLCFull Year Results
Taylor Wimpey PLCTrading Statement
Unilever PLCTrading Statement
United Oil & Gas PLCFull Year Results
Weir Group PLCTrading Statement
WPP PLCTrading Statement
Friday 28 April 
Alphawave IP Group PLCFull Year Results
Alphawave IP Group PLCTrading Statement
Argo Blockchain PLCfull Year Results
Computacenter PLCTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Industrials REIT LtdTrading Statement
James Fisher & Sons PLCFull Year Results
Kingspan Group PLCTrading Statement
LMS Capital PLCTrading Statement
Morgan Advanced Materials PLCFull Year Results
NatWest Group PLCQ1 Results
Nostrum Oil & Gas PLCTrading Statement
Pearson PLCTrading Statement
PureTech Health PLCFull Year Results
Record PLCTrading Statement
Renishaw PLCTrading Statement
Rotork PLCQ1 Results
Smurfit Kappa Group PLCTrading Statement
Westminster Group PLCFull Year Results
Monday 1 May 
no events scheduled 
Tuesday 2 May 
BP PLCQ1 Results
Facilities by ADF PLCFull Year Results
HSBC Holdings PLCQ1 Results
Wednesday 3 May 
Aston Martin Lagonda Global Holdings PLCQ1 Results
Ashtead Technology Holdings PLCFull Year Results
Barratt Developments PLCTrading Statement
Bank of Ireland Group PLCTrading Statement
Cambridge Cognition Holdings PLCFull Year Results
Card Factory PLCFull Year Results
Coca-Cola HBC AGTrading Statement
Flutter Entertainment PLCTrading Statement
Haleon PLCTrading Statement
Inspiration Healthcare Group PLCFull Year Results
Lords Group Trading PLCFull Year Results
Metro Bank PLCTrading Statement
Permanent TSB Group Holdings PLCTrading Statement
OSB Group PLCTrading Statement
Smiths News PLCHalf Year Results
Ten Lifestyle Group PLCHalf Year Results
TI Fluid Systems PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
12 Apr 2023 14:32

Cambridge Cognition wins two contracts worth £2.1m

(Sharecast News) - Brain health technology specialist Cambridge Cognition has won two contracts worth more than £2.1m, it announced on Wednesday.

Read more
12 Apr 2023 12:30

IN BRIEF: Cambridge Cognition wins two contracts worth GBP2.1 million

Cambridge Cognition Holdings PLC - Cambridge, England-based technology company developing digital health products to better understand, detect and treat conditions affecting brain health - Wins two contracts worth GBP2.1 million to provide its CANTAB cognitive assessments and electronic Clinical Outcome Assessments for two trials involving patients "with a rare disease". Says that the contracts have been awarded by a new customer, and expects revenues to be recognised over the next five years.

Read more
6 Feb 2023 15:11

Director dealings: Cambridge Cognition CEO makes share purchase

(Sharecast News) - Cambridge Cognition revealed on Monday that chief executive Matthew Stork had acquired 13,500 ordinary shares in the AIM-listed technology company.

Read more
3 Feb 2023 13:41

TRADING UPDATES: Somero revenue short of outlook; SigmaRoc optimistic

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
11 Jan 2023 11:37

Cambridge Cognition acquires Winterlight Labs for GBP7.0 million

(Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it acquired cognitive impairment monitoring developer Winterlight Labs for GBP 7.0 million.

Read more
24 Nov 2022 13:30

Cambridge Cognition finds local partner for China expansion

(Sharecast News) - Brain health technology developer Cambridge Cognition announced an expansion in the Chinese market through a strategic partnership with Luca Healthcare on Thursday.

Read more
24 Nov 2022 11:54

Cambridge Cognition signs deal with Luca Healthcare to expand in China

(Alliance News) - Cambridge Cognition PLC on Thursday said it had signed a strategic partnership with Luca Healthcare Ltd to expand its operations in China.

Read more
19 Oct 2022 16:41

TRADING UPDATES: Smiths News, Cambridge Cognition win contracts

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
12 Oct 2022 14:29

IN BRIEF: Cambridge Cognition buys eClinicalHealth for GBP1.7 million

Cambridge Cognition Holdings PLC - Cambridge-based brain health assessment software provider - Buys virtual clinical trial solution provider eClinicalHealth Ltd for up to GBP1.7 million. Says the opportunity shows an exciting opportunity to expand its virtual clinical trials offering in a rapid growth market.

Read more
12 Oct 2022 13:01

Cambridge Cognition agrees £1.7m purchase of eClinicalHealth

(Sharecast News) - Brain health specialise Cambridge Cognition has agreed to acquire virtual clinical trial solution provider eClinicalHealth (eCH), it announced on Wednesday, for up to £1.7m.

Read more
20 Sep 2022 09:34

Cambridge Cognition profits fall despite significant rise in revenue

(Alliance News) - Cambridge Cognition PLC on Tuesday reported a big drop in profit, even as revenue grew significantly.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.